BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16193709)

  • 1. [Development of slides for Epstein-Barr virus diagnosis by indirect immunofluorescence].
    Pérez GR; Taborda MA; Toffi A; Palonsky M; Pagotto M; Gardiol DN; Giri AA
    Medicina (B Aires); 2005; 65(4):315-20. PubMed ID: 16193709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
    Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
    Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgA antibodies against Epstein-Barr virus capsid antigen].
    Chalupa P; Slesinger P; Krchnáková A; Prásek J
    Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
    Dong L; Masaki Y; Takegami T; Kawanami T; Itoh K; Jin ZX; Huang CR; Tong XP; Fukushima T; Tanaka M; Sawaki T; Sakai T; Sugai S; Okazaki T; Hirose Y; Umehara H
    Int Immunol; 2007 Mar; 19(3):331-6. PubMed ID: 17272286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic study of Epstein-Barr virus serologic assays following acute infection.
    Rea TD; Ashley RL; Russo JE; Buchwald DS
    Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.
    Sener AG; Afsar I; Pinar E
    J Virol Methods; 2009 Aug; 159(2):300-2. PubMed ID: 19406156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C; Agawa H; Sairenji T; Inoue Y
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the serological diagnosis of Epstein-Barr virus among patients with mononucleosis].
    Liu CY; Yan J; Liu YY; Xie ZD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Sep; 28(9):898-900. PubMed ID: 18251276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
    Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
    J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
    Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
    J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three different assays for the assessment of Epstein Barr Virus immunological status.
    Altuglu I; Bozkurt H; Samlioglu P; Zeytinoglu A
    New Microbiol; 2007 Oct; 30(4):393-8. PubMed ID: 18080674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of a dot-blot technique for the detection of Epstein-Barr virus antibodies (IgG anti-viral capsid antigen)].
    Bouillet L; Cattoen C; Keilani A; Chatelain C; Mazars E
    Ann Biol Clin (Paris); 1998; 56(1):79-83. PubMed ID: 9754226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.